Login / Signup
What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective.
Yinglian Hu
Simiao Chen
Published in:
Journal of travel medicine (2021)
Keyphrases
</>
healthcare
coronavirus disease
mental health
sars cov
public health
drug induced